I now have comprehensive material to write a thorough 10-mark MD exam answer on CPET. Let me compose it:
Cardiopulmonary Exercise Test (CPET)
Definition
Cardiopulmonary exercise testing (CPET) is the reference standard test for the assessment of exercise intolerance and dyspnea. It provides a systematic, integrated evaluation of the cardiac, pulmonary, metabolic, and neuromuscular responses to incremental exercise, thereby identifying which system primarily limits exercise capacity. - Murray & Nadel's Textbook of Respiratory Medicine
Principle
CPET is based on the Fick equation, which describes oxygen delivery:
VO2 = Q x (CaO2 - CvO2)
Where VO2 = oxygen consumption, Q = cardiac output, CaO2 = arterial O2 content, CvO2 = mixed venous O2 content.
During progressive exercise, oxygen consumption rises proportionally with work rate. The body's ability to sustain this rise depends on coordinated increases in ventilation, cardiac output, and peripheral O2 extraction. CPET captures this integrated response through breath-by-breath gas analysis combined with ECG monitoring and blood pressure measurement.
Equipment / Setup
- Cycle ergometer (preferred) or treadmill
- Pneumotachograph or turbine for airflow measurement
- Rapid gas analyzers for O2 and CO2 (breath-by-breath)
- 12-lead ECG monitoring
- Pulse oximetry (SpO2)
- Blood pressure monitoring
- Mouthpiece with nose clip, or face mask
Protocol
Standard incremental (ramp) protocol:
- Rest (3 min) - baseline gas exchange and HR recorded
- Unloaded pedalling (3 min) - warm-up at 0 watts
- Incremental work - workload increased progressively (e.g., 10-25 W/min based on predicted fitness)
- Peak exercise - symptom-limited maximum effort
- Recovery (3 min)
The Wasserman 9-panel (9-box) plot displays all key variables graphically in standardized format for systematic interpretation. - Murray & Nadel's
Key Parameters Measured
| Parameter | Normal value / Significance |
|---|
| Peak VO2 (mL/kg/min) | Most important single parameter; reflects overall cardiorespiratory fitness |
| Anaerobic Threshold (AT) / Ventilatory Threshold (VT) | VO2 level where anaerobic metabolism begins; normally >40% of predicted VO2max |
| VE/VCO2 slope | Ventilatory efficiency; normal <30; raised in heart failure and pulmonary hypertension |
| O2 pulse (VO2/HR) | Surrogate for stroke volume; reduced in cardiac disease |
| Breathing Reserve (BR) | Peak VE / MVV; normally >15-20 L; reduced in ventilatory limitation |
| RER / Respiratory Exchange Ratio | VCO2/VO2; >1.10 confirms maximal effort |
| Heart Rate Reserve | Predicted max HR minus achieved HR; >15 bpm suggests non-cardiac limitation |
| SpO2 | Significant desaturation (>4%) suggests pulmonary vascular disease or shunt |
| End-tidal PCO2 (PETCO2) | Rises with ventilatory limitation (COPD); falls with cardiac and pulmonary vascular disease |
| VD/VT (dead space ratio) | Elevated in pulmonary hypertension |
Indications
- Evaluation of unexplained dyspnea - to distinguish cardiac vs. pulmonary vs. other causes
- Functional capacity assessment in heart failure (HF) for prognosis and transplant listing
- Pre-operative risk assessment before major surgery (especially thoracic and cardiac surgery)
- Pulmonary rehabilitation - exercise prescription
- Assessment of disability - impairment rating
- Pulmonary hypertension - severity and prognosis
- Heart transplant candidacy - peak VO2 <14 mL/kg/min (or <12 on beta-blockers) = listing criterion
- Congenital heart disease - serial monitoring of functional decline, timing of intervention
- Differentiation of true angina from other causes of chest pain on exertion
- Response to therapy (e.g., after cardiac resynchronization therapy)
- Braunwald's Heart Disease; Murray & Nadel's; Bailey & Love's Surgery
Contraindications
Absolute:
- Active myocardial ischemia / MI within 30 days
- Acute heart failure exacerbation
- Severe aortic stenosis
- Uncontrolled arrhythmias
- Acute endocarditis, myocarditis, pericarditis
- Acute aortic dissection
- Acute pulmonary embolism / DVT
- Active COPD exacerbation or uncontrolled asthma
- Active pulmonary edema
- SpO2 <85% at rest on room air
- Exercise-induced syncope
Relative:
-
Severe pulmonary hypertension
-
Left main coronary artery stenosis
-
Moderate stenotic valve disease
-
Severe hypertension (SBP >200 or DBP >120 mmHg)
-
Hypertrophic cardiomyopathy
-
High-degree AV block
-
Advanced/complicated pregnancy
-
Murray & Nadel's Textbook of Respiratory Medicine, Table 33.1
Interpretation: Distinguishing Cardiac vs. Pulmonary Limitation
| Feature | Cardiac Limitation | Pulmonary Limitation (e.g., COPD) |
|---|
| Peak VO2 | Reduced | Reduced |
| AT | Early (low) | May be normal or absent |
| VE/VCO2 slope | Elevated (>34) | Normal or elevated |
| Breathing Reserve | Normal (>15%) | Reduced (<15%) |
| O2 pulse | Reduced (flat curve) | Normal |
| PETCO2 at peak | Decreased | Stable or increased |
| SpO2 | Usually maintained | May desaturate |
| Heart Rate Reserve | Low | High (HR reserve preserved) |
Prognostic Values in Heart Failure
CPET is used to time heart transplantation:
-
Peak VO2 >14 mL/kg/min - 94% one-year survival; transplant can be deferred
-
Peak VO2 <14 mL/kg/min (or <12 on beta-blockers) - high mortality; transplant listing considered
-
VE/VCO2 slope >34 - elevated mortality risk; slope >40 with peak VO2 <10 = worst prognosis
-
Other adverse prognostic markers: exercise oscillatory ventilation (EOV), poor heart rate recovery, flat O2 pulse
-
Murray & Nadel's, Braunwald's Heart Disease
Impairment Classification (ATS Criteria)
| Peak VO2 (mL/kg/min) | Impairment Level |
|---|
| >25 | Capable of all but most physically demanding jobs |
| 15-25 | Able to perform jobs not requiring sustained work >40% VO2max |
| <15 | Unable to perform most jobs |
Safety
The risk of complications requiring hospitalization is <0.2%; serious arrhythmia risk <0.04%; cardiac death risk <0.01%. The test must always be performed with a physician present and resuscitation equipment immediately available. - Murray & Nadel's
Summary
CPET is the most comprehensive non-invasive test of cardiorespiratory fitness. Its unique strength lies in simultaneous measurement of cardiac, ventilatory, and metabolic responses during stress, allowing precise identification of the limiting system. The three most clinically important parameters are peak VO2 (overall capacity), VE/VCO2 slope (ventilatory efficiency/prognosis), and anaerobic threshold (submaximal exercise tolerance). In heart failure, CPET directly guides the critical decision of transplant listing.
Sources:
- Murray & Nadel's Textbook of Respiratory Medicine (Chapter 33: Cardiopulmonary Exercise Testing)
- Braunwald's Heart Disease, 2-Volume Set (Chapter 51: HFpEF)
- Fuster & Hurst's The Heart, 15th Edition
- Bailey & Love's Short Practice of Surgery, 28th Edition